• Who We Are
    • Letter from the CEO
    • About Us
    • Our Team
  • Science
  • Pipeline
    • Pipeline Overview
    • NVD-003
    • NVD-X3
  • Patients
  • Investors
  • Contact
  • Careers
What's New
  • Home
  • Who We Are
    • Letter from the CEO
    • About Us
    • Our Team
  • Science
  • Pipeline
    • Pipeline Overview
    • NVD-003
    • NVD-X3
  • Patients
  • Investors
  • What’s New
  • Contact
  • Careers

Encouraging results in the reconstruction process bone for NOVADIP

by Novadip | May 13, 2020 | Press Releases

Read this interview (French article) of our CEO Denis Dufrane in the newspaper “Trends Tendances” of this May 13, 2020. Trends 13 mai 2020 Résultats encourageants pour Novadip dans la reconstruction osseuse

Shinichi Tamura reclaims the throne at Sosei; Jeff Abbey exits Argos for Novadip; Frank Czerwiec is the new CMO at Goldfinch

by Novadip | Dec 14, 2018 | Featured News

Jeff Abbey is jumping to the helm of Belgium’s Novadip Biosciences after leading Argos Therapeutics as president and CEO for the past eight years.

Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction

by Novadip | Feb 2, 2017 | Publications

February 2, 2017 | Arthroscopy: The Journal of Arthroscopic & Related Surgery Volume 33, Issue 2 | Tatsuhiro Toratani, Junsuke Nakase, Hitoaki Numata, Takeshi Oshima, Yasushi Takata, Koichi Nakayama, Hiroyuki Tsuchiya

Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells Compared with Dermal Fibroblasts and Keratinocytes: Importance for Would Healing in Type 2 Diabetes

by Novadip | Dec 19, 2016 | Publications

December 19, 2016 | Plos One Collection Nanomaterials | Aurore Lafosse, Cecile Dufeys, Christophe Beauloye, Sandrine Horman, Denis Dufrane

A Simple Method to Determine the Purity of Adipose-Derived Stem Cell-Based Cell Therapies

by Novadip | Jul 8, 2016 | Publications

July 8, 2016 | Stem Cells Translational Medicine | Denis Dufrane, Aurore Lafosse
« Older Entries
Next Entries »

Stay Updated by Joining Our Email List

Success!

Subscribe

NOVADIP

Novadip is advancing the standard of care
in bone and tissue regenerative medicine

info@novadip.com

+32 (10) 779 220

Navigation

Who We Are

Our Science

Our Pipeline

Patients

Investors

What’s New

Get In Touch

Contact

Careers

Legal

Privacy Policy

Cookie Policy

Information Notice

Proposed Expanded Access Policy

©2022 NOVADIP. All Rights Reserved.

  • Follow